Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershberg

Attempting "Moneyball for biotech"

Welcome to The Century of Biology! This newsletter explores data, companies, and ideas from the frontier of biology. You can subscribe for free to have the next post delivered to your inbox: What I initially thought would be a summer hiatus stretched into a longer break from regular writing. But I’ve now defended my PhD (🍾🍾) and am excited to have more mental bandwidth for CoB again! And I’ll have more to share about what I’m doing next… soon. 👀 For now, I’m back with a detailed profile of one of the companies I’m most intrigued by. Enjoy! 🧬 In 1994, Jeff Bezos left a high-paying…

related reading

• Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
• Curious cases of financial engineering in biotechowlposting.com
• Tech vs Biotech - Celine Haliouacelinehh.com
• Where are all the trillion dollar biotechs?ladanuzhna.xyz
• On AI Infrastructure in Biology - by Elliot Hershbergcenturyofbio.com
• Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
• Techbio taxonomycenturyofbio.substack.com
• AI Versus Eroom's Lawsubstack.com
• Rebuild Biotech for the AI Era | Benchlingbenchling.com
• Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
• Anatomy of a Biotech Business Development Deal | Andreessen Horowitza16z.com
• Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com